| Prev Close: | 43.76 |
|---|---|
| Open: | 43.82 |
| Bid: | 43.52 x 1000 |
| Ask: | 43.53 x 800 |
| 1y Target Est: | 39.30 |
| Beta: | 0.12 |
| Next Earnings Date: | 22-Jul-13 |
| Day's Range: | 43.45 - 44.44 |
|---|---|
| 52wk Range: | 30.64 - 45.59 |
| Volume: | 2,817,682 |
| Avg Vol (3m): | 10,019,000 |
| Market Cap: | 71.62B |
| P/E (ttm): | 49.29 |
| EPS (ttm): | 0.88 |
| Div & Yield: | 1.40 (3.20%) |
Quotes delayed, except where indicated otherwise. Currency in USD.
Headlines
- After A Big Rally, Pfizer Might Need Some Restat Investopedia(Tue 11:45AM EDT)
- Cramer: Buy BioMarin Pharma, Bristol-Myers Squibb, Asbury Automotive, But Sell These 2 Stocksat Wall St. Cheat Sheet(Tue 11:37AM EDT)
- Early Glance: Pharmaceuticals companiesAP(Tue 10:36AM EDT)
- Bristol-Myers Squibb Director Sells More Than 215K Shares and 4 Insider Sales to Noteat Wall St. Cheat Sheet(Tue 9:40AM EDT)
- Cramer's Top Stock Picks: SAVE GILD BMY HTA TSLAat TheStreet(Tue 6:00AM EDT)
- Cramer's Watch List Ahead of Big Cancer Conferenceat CNBC(Mon May 20)
- [video] The War Against Cancerat CNBC(Mon May 20)
- Final Glance: Pharmaceuticals companiesAP(Mon May 20)
- Teva Bets on Reformulating Old Drugs as Investors Say ‘Show Me’at Bloomberg(Mon May 20)
- Bristol Myers Squibb And The New Wave Of Cancer Drugsat Seeking Alpha(Mon May 20)
- Will Amgen's Novel Drug Revolutionize Cancer Treatment?at Motley Fool(Mon May 20)
- Midday Glance: Pharmaceuticals companiesAP(Mon May 20)
- 5 Drugs Stocks On The Riseat TheStreet(Mon May 20)
- 1 Pioneering Device to Jump-Start the Cardiovascular Industryat Motley Fool(Mon May 20)
- Shire advances after report renews takeover speculationat theflyonthewall.com(Mon May 20)
Press Releases
- Finding the Next Big Blockbuster DrugAccesswire(Thu May 16)
- BMY, LLY, ENDP, and AGN Early Briefing and ReviewAccesswire(Tue Apr 30)
- High Rates of SVR Demonstrated in Phase II Study with Investigational Triple DAA Regimen of Daclatasvir, Asunaprevir and BMS-791325 in Treatment-Naïve Patients with Genotype 1 Chronic Hepatitis C InfectionCNW Group(Tue Apr 23)
Must Read
- Exclusive: Glencore's top aluminum exec to leave, first exit since takeover-sourcesReuters(1969-12-31T18:59:59GMT-05:00)
- Sprint raises Clearwire offer, not enough for someReuters(1969-12-31T18:59:59GMT-05:00)
- Ireland rejects blame for Apple's low tax rateReuters(1969-12-31T18:59:59GMT-05:00)
- Canada bank regulator says watching housing risk, pleased so farReuters(1969-12-31T18:59:59GMT-05:00)
- Shell says hunt for new CEO is underwayReuters(1969-12-31T18:59:59GMT-05:00)